Pethema Foundation
Clinical trials sponsored by Pethema Foundation, explained in plain language.
-
Hope for AML patients: new Three-Drug combo aims to extend lives
Disease control Not yet recruitingThis study tests whether adding a third drug (quizartinib) to the usual two-drug therapy (venetoclax and azacytidine) helps adults with newly diagnosed acute myeloid leukemia (AML) live longer. Participants are people who cannot receive standard strong chemotherapy due to age or …
Phase: PHASE3 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
New pill combo offers hope for older leukemia patients who Can't handle chemo
Disease control Not yet recruitingThis study tests whether a combination of two oral medications (decitabine and ivosidenib) can help older adults (60+) or those with other health issues who have a specific genetic type of acute myeloid leukemia (AML). The goal is to see if the treatment can put the leukemia into…
Phase: PHASE2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New immunotherapy combo aims to boost leukemia survival in adults
Disease control Not yet recruitingThis study tests a new treatment protocol for adults up to age 65 with a type of leukemia called Ph-negative ALL. The goal is to see if adding an immunotherapy drug called blinatumomab and adjusting chemotherapy can improve survival compared to an older treatment plan. About 330 …
Phase: NA • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated May 11, 2026 20:39 UTC